Menu

Huge Gender Disparity in Cancer Research Funding in U.K.

Men received both more and larger grants than women did, ending up with three times as much funding on average.

May 16, 2018
Shawna Williams

ISTOCK, TSVIBRAVBetween 2000 and 2013, women received just 31 percent of the number of cancer research grants awarded in the U.K., and 22 percent of the total funds to investigate cancer, according to an analysis published Tuesday (May 14) in BMJ Open. “We would strongly urge policy-makers, funders and the academic and scientific community to investigate the factors leading to our observed differences and seek to ensure that women are appropriately supported in scientific endeavour,” the authors write in the paper.

The analysis examined data on both public and philanthropic grants given to support cancer research in the U.K. Male PIs were awarded 69 percent of the grants, and their grants were on average 1.3 times as large as those given to women, so that they received 78 percent of the total money allocated.

“The significant concern following such an apparent gender imbalance is the possibility of bias or inequality against women researchers, which must be addressed,” coauthor Mahiben Maruthappu tells Medscape Medical News.

Gender disparities in the sciences are well-established. For example, female PhD students tend to publish less than their male counterparts and women are less likely to have opportunities to speak at conferences or to be successful when applying for patents. The authors of the paper note that “just one in five countries worldwide has achieved gender parity in scientific research (defined as when 45% to 55% of researchers are women).”

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.